
James Taylor VI MD
Sickle Cell & Other Anemias
Director, Center for Sickle Cell Disease, Howard University ; Professor of Medicine and Microbiology, Howard University College of Medicine
Join to View Full Profile
2041 Georgia Ave NWWashington, DC 20060
Phone+1 612-625-1110
Fax+1 202-865-5018
Dr. Taylor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- James Taylor VI, MD, is a hematologist specializing in sickle cell and other anemias, based in Washington, DC. He completed his fellowship in Pediatric Hematology/Oncology at Johns Hopkins University and his pediatrics residency at the Washington University/B-JH/SLCH Consortium. Currently an Attending Physician at Howard University Hospital and a Professor at Howard University College of Medicine, he previously served as a Clinical Investigator at the NIH Clinical Center. His research focuses on conditions such as pulmonary hypertension and hemolytic anemia, and he has published extensively in this field, including articles on sickle cell disease. Dr. Taylor has been involved in several clinical trials related to sickle cell disease. He has received honors such as the John Benjamin Nichols Award and a Humanitarian Award from QSCAN/SCDAA. He also holds an appointment in the Department of Microbiology and Immunology at Howard University for training MS and PhD students.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 1995 - 1998
Medical College of WisconsinClass of 1995
Certifications & Licensure
DC State Medical License 2016 - 2026
MD State Medical License 2001 - 2025
MO State Medical License 1997 - 2022
MN State Medical License 2016 - 2018
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- John Benjamin Nichols Award Medical Society of the District of Columbia, 2023
- Humanitarian Award Queens Sickle Cell Action Network (QSCAN)/SCDAA, 2019
Clinical Trials
- Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia Start of enrollment: 2008 Feb 19
- Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria Start of enrollment: 2006 Jun 15
- Genetics and Pain Severity in Sickle Cell Disease Start of enrollment: 2012 Jun 17
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsRiociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.Mark T Gladwin, Victor R Gordeuk, Payal C Desai, Caterina Minniti, Enrico M Novelli
The Lancet. Haematology. 2024-05-01 - 2 citationsAntiviral response and HIV-1 inhibition in sickle cell disease.Namita Kumari, Asrar Ahmad, Clemilson Berto-Junior, Andrey Ivanov, Fayuan Wen
Iscience. 2024-02-16 - 2 citationsSoluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease.Nowah Afangbedji, Namita Kumari, Sharmin Diaz, Fayuan Wen, James G Taylor
Blood Advances. 2023-05-09
Press Mentions
The Battle Unseen: How Mental Health Care, Holistic Medicine, and Hope Could Change Sickle Cell DiseaseSeptember 17th, 2025
Cures for Sickle Cell Disease Arrive After a Painful JourneySeptember 17th, 2024
Hematologists consider where new therapies fit in sickle cell treatment paradigmDecember 19th, 2023- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- French
External Links
- ORCIDhttps://orcid.org/0000-0002-4421-1809
- Scopus profilehttps://www.scopus.com/authid/detail.uri?authorId=7405408594
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









